What did @david_padilla86 actually say?
The creator says he's taking GHK-Cu and plans to run it until he can "grow my hairline back," estimating about 30 days. He frames this as a potential alternative to a hair transplant in Turkey. That's a bold promise to hang on a single peptide with a limited human trial record.
To be fair, he's not selling anything here, and he's framing this as personal experimentation, not medical advice. He says "hopefully" multiple times, which at least signals some uncertainty. But 598,000 viewers are watching someone imply that a peptide can restore a receding hairline in a month, and that framing deserves a hard look at what the actual evidence says, because it's a lot thinner than the TikTok comment section probably assumes.
Does the science back this up?
There is legitimate research on GHK-Cu and hair growth, but the evidence base is narrower and more preliminary than this video implies. The gap between cell culture findings and your actual hairline is enormous.
GHK-Cu (copper peptide GHK) has shown activity in studies involving hair follicle stimulation. Pickart and Margolina (2018, Biomolecules) reviewed GHK-Cu's regenerative signaling properties, noting it activates genes involved in tissue remodeling and growth factor expression. Specific to hair, a study by Uno and colleagues found copper peptides increased follicle size in animal models. However, animal and in-vitro data do not translate automatically to "regrow your hairline in 30 days" in a human with androgenetic alopecia.
The more relevant question is whether GHK-Cu works on androgenetic alopecia, which is what a receding hairline typically indicates. That form of hair loss is driven primarily by DHT sensitivity in genetically predisposed follicles. GHK-Cu does not block DHT. There are no peer-reviewed randomized controlled trials in humans showing GHK-Cu reverses androgenetic alopecia. The two interventions with actual human RCT evidence for that condition are minoxidil and finasteride.
What did they get wrong (or right)?
What he got wrong is the implicit 30-day timeline and the framing that GHK-Cu is a credible standalone alternative to a hair transplant for hairline restoration. Those are different categories of intervention. A transplant physically relocates DHT-resistant follicles. GHK-Cu, at best, may support follicle health through growth factor signaling. Conflating them misleads viewers who might delay effective treatment.
What he got right, accidentally, is that GHK-Cu is not a completely fringe compound. It has a real research profile in wound healing and skin regeneration. Pickart (2008, Journal of Biomaterials Science) documented GHK's role in collagen synthesis and anti-inflammatory signaling. Some dermatologists do consider topical copper peptides a reasonable adjunct for hair health, particularly in non-androgenetic thinning. That's not nothing. But "adjunct for hair health" and "bring my hairline back" are not the same sentence.
- GHK-Cu has documented activity in tissue repair signaling
- No human RCTs confirm it reverses androgenetic alopecia
- The 30-day claim has no clinical basis
- DHT-driven hair loss requires DHT-targeting interventions
What should you actually know?
If you have a receding hairline and you're researching peptides instead of seeing a dermatologist, you're probably working in the wrong direction. Androgenetic alopecia progresses while you experiment, and the window for preserving existing follicles matters.
GHK-Cu is a naturally occurring tripeptide found in human plasma, and its safety profile in topical use is generally considered acceptable based on available data. Systemic peptide use for hair growth is a different matter, and the route of administration this creator is using isn't specified in the clip. If injected, that's an off-label, unregulated use with no standardized dosing evidence for this purpose.
The compounds with the strongest evidence for androgenetic alopecia remain finasteride (Kaufman et al., 1998, Journal of the American Academy of Dermatology) and minoxidil, both of which have decades of human trial data. Neither is perfect. But a 30-day GHK-Cu experiment documented on TikTok is not a clinical trial, and its outcome, whatever it is, tells you almost nothing generalizable about whether the peptide works for hair loss.
If you're curious about peptides in a dermatology context, that's a conversation worth having with a licensed provider who can review your specific situation and bloodwork, not a TikTok comment thread.